OTC · HPST
Hempstract, Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
$0.03
Up+$0.00 (+2.04%)
Updated Sep 19, 2026, 5:21 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 25.55M
- P/E ratio
- -82.12
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 16.6K
- Avg. volume
- 32.62K
Price performance
HPST price history
1M range · 0 trading sessions · Daily adjusted prices
HPST does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest HPST news
The latest Smart Investors Daily articles mentioning HPST.
Stock researchCompany · Overview
HPST research
Overview
Company profile and research snapshot.
Company profile
Hempstract, Inc. produces and sells cannabidiol (CBD) and cannabigerol solutions in the United States. It offers CBD isolate powder and distillate oil. The company was formerly known as Riverdale Oil and Gas Corporation and changed its name to Hempstract, Inc. in November 2020. Hempstract, Inc. is based in Warden, Washington.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
